Instalimb, Developer of 3D-Printed Prosthetic Legs, Selected for Tokyo's Global Startup Support Program 'SusHi Tech Global' Cohort 4

Instalimb Co., Ltd. (Headquarters: Sumida City, Tokyo; CEO: Yasushi Tokushima; hereinafter "the Company"), a pioneer in the world's first (※1) AI-driven 3D-printed prosthetic limb manufacturing solution deployed in Japan, India, and the Philippines, announces its selection as one of the 17 participating companies in the fourth cohort of Tokyo Metropolitan Government's global startup support program, "SusHi Tech Global."

With the support from this program, the Company will advance its vision of "realizing a world where everyone in need can access high-quality prosthetics." This includes further strengthening its existing overseas operations, expanding into third countries via a franchise model, and developing a remote delivery system utilizing smartphone scanning technology. These initiatives aim to transcend the traditional limitations of prosthetic provision—which has historically required access to urban centers or specialized facilities—and establish a new global supply infrastructure to deliver high-quality prosthetics to underserved populations.

About "SusHi Tech Global"

In November 2025, the Tokyo Metropolitan Government launched the "Global Innovation Strategy 2.0 STARTUP & SCALEUP," positioning global scale-up support as a core pillar. Under this strategy, "SusHi Tech Global" was established as a public-private initiative to concentrate support on startups leveraging sustainable technologies to drive social transformation and global growth.

Since the first cohort in December 2025, 77 companies have participated. With the announcement of the fourth cohort on July 9, 2026, 17 new companies—including Instalimb—have been selected, bringing the total to 94.

### Support Programs

- Growth Acceleration Program: Up to 200 million JPY in funding support and hands-on assistance - Energy and Resilience Enhancement Program: Up to 200 million JPY in funding and operational support - Global × Scale-up Program: Selected graduates will receive up to 1 billion JPY in funding support

Future Outlook

To date, the Company has focused on addressing the social challenge of prosthetic shortages in the Global South, advancing direct-operated clinic operations in India and the Philippines, and providing 3D prosthetic manufacturing solutions to government agencies and large organizations.

Moving forward, the Company will leverage its expertise in D2C sales, digital manufacturing, and local operations gained in existing markets to expand its franchise model into countries and regions beyond India and the Philippines, thereby establishing systems to deliver high-quality prosthetics to populations previously underserved by traditional models. Additionally, the Company will implement a remote delivery model by advancing the development of smartphone scanning technology, enabling service delivery to remote patients who face difficulties accessing clinics or specialized equipment.

Through these initiatives, the Company aims to overcome the traditional limitations of prosthetic provision—long dependent on access to urban centers and specialized facilities—and realize a new, globally scalable supply infrastructure. The Company will continue its global mission to achieve its vision of "a world where everyone in need can access high-quality prosthetics."

About Instalimb

Instalimb is a Japan-born deep-tech startup that pioneered the world's first (※1) practical application of 3D-printed prosthetic legs. Founded in March 2017, the Company began preparations for operations in the Philippines in April 2018 and has since progressively scaled its business in the Philippines and India.

The "3D-printed prosthetic leg" product delivers quality comparable to conventional prosthetics at less than 1/10 the cost. As a "3D prosthetic manufacturing solution," it reduces lead times and initial costs to less than 1/10 of traditional methods while increasing the production capacity per prosthetist by more than 10 times.

In direct-to-consumer sales, the Company has already manufactured and sold over 9,000 prosthetics in the Philippines and India. Its solution has been adopted by more than 10 organizations, including public institutions worldwide. The Company operates globally with a team of approximately 250 people.

(From left) Instalimb's 3D-printed prosthetic leg, 3D printer developed and manufactured by Instalimb for prosthetics, and 3D-CAD software developed by Instalimb for prosthetic design

Company Overview

Company Name: Instalimb Co., Ltd.

Representative: CEO Yasushi Tokushima

Founded: March 2017

Established (Operations Start): April 2018

Capital: 100 million JPY

Business: Development, manufacturing, and sales of 3D-printed prosthetics and manufacturing equipment

URL: https://www.instalimb.com/

Locations

Japan (Global HQ): 1-16-3 Yokokawa, Sumida-ku, Tokyo

India (India HQ): 592, Udyog Vihar, Phase 5, Gurugram, Haryana, India.

Philippines (Philippines HQ): Unit 2503, Centuria Medical Makati, Kalayaan Avenue, Brgy. Poblacion, Makati City, Metro Manila, Philippines.

※1: World's first = Based on Instalimb's research (web articles, news reports, academic papers). Refers to a commercially viable, mass-customized production system using 3D printers and CAD for prosthetics, not merely prototype distribution. Mass customization refers to a production system that combines personalized customization with low-cost, high-volume supply.